RCP Diagnostics LLC

The principal goal of RCP Diagnostics is to commercialize a blood-based diagnostic for estrogen-associated cancers in women. The assay, initially developed as a radioimmunoassay, detects the presence of a protein that ferries vitamin B-2, or riboflavin, throughout the body.